| Literature DB >> 31193899 |
Bhargavi Gali1, Sarah R Gritzner2, Amy J Henderson2, Mary E Warner1, Sinokuthaba L Sibanda3, Juraj Sprung1, Toby N Weingarten1.
Abstract
OBJECTIVE: To assess the rate of postanesthesia respiratory depression (RD) and test for potential associations with clinical characteristics of patients undergoing urogynecologic procedures at ambulatory surgical centers (ASCs). Postanesthesia RD is poorly characterized for patients undergoing urogynecologic procedures in ASCs. PATIENTS AND METHODS: Health records of adult patients undergoing urogynecologic procedures at an ASC from July 1, 2010, through December 31, 2015, were abstracted. Cases complicated by RD were identified, and analyses of risk factors were performed with generalized estimating equations (GEE).Entities:
Keywords: ASC, ambulatory surgical center; BMI, body mass index; CPAP, continuous positive airway pressure; IQR, interquartile range; OR, odds ratio; OSA, obstructive sleep apnea; PACU, postanesthesia care unit; RD, respiratory depression; SpO2, oxygen saturation as measured by pulse oximetry
Year: 2019 PMID: 31193899 PMCID: PMC6543496 DOI: 10.1016/j.mayocpiqo.2019.02.002
Source DB: PubMed Journal: Mayo Clin Proc Innov Qual Outcomes ISSN: 2542-4548
FigureIncidence of respiratory depression following ambulatory urologic and gynecologic procedures under anesthesia. Diamonds indicate point estimates; error bars indicate the upper and lower bounds of the 95% confidence intervals.
Respiratory Depression During Anesthesia Recovery Following Ambulatory Urogynecologic Procedures
| Patient Characteristics | Respiratory depression (n=221) | No respiratory depression (n=8920) | Odds Ratio (95%CI) | ||
|---|---|---|---|---|---|
| Age, mean (SD), years | 65.6 (12.1) | 58.4 (16.7) | <.001 | .001 | |
| <50 | Reference | ||||
| 50-59 | 2.48 (1.40-4.41) | ||||
| 60-69 | 2.75 (1.57-4.81) | ||||
| ≥70 | 2.98 (1.70-5.22) | ||||
| Male sex | 191 (86.4) | 4,713 (52.8) | <.001 | 3.73 (2.43-5.73) | <.001 |
| Morbid obesity | 31 (14.0) | 489 (5.5) | <.001 | 2.02 (1.25-3.25) | .014 |
| Obstructive sleep apnea | 100 (45.2) | 1,074 (12.0) | <.001 | 3.68 (2.68-5.04) | <.001 |
| Cardiovascular disease | 42 (19.0) | 758 (8.5) | <.001 | 1.26 (0.85-1.87) | .28 |
| Diabetes mellitus | 62 (28.7) | 1,017 (11.8) | <.001 | 1.39 (0.98-1.96) | .08 |
| Pulmonary disease | 28 (12.7) | 961 (10.7) | .51 | 0.82 (0.52-1.27) | .34 |
| Home opioids | 132 (59.7) | 4,063 (45.6) | <.001 | 1.14 (0.85-1.53) | .38 |
| Home benzodiazepine | 18 (8.1) | 811 (9.1) | .45 | 0.80 (0.47-1.36) | .37 |
| Surgical duration, mean (range), min | 40 (23-69) | 25 (15-50) | <.001 | .89 | |
| <15 | Reference | ||||
| 15-29 | 1.23 (0.76-2.00) | ||||
| 30-44 | 1.29 (0.76-2.17) | ||||
| 45-59 | 1.24 (0.70-2.19) | ||||
| ≥60 | 1.24 (0.74-2.07) | ||||
| Anesthesia | |||||
| Airway management | <.001 | ||||
| Native | 18 (8.1) | 2194 (24.6) | Reference | ||
| Secured | 203 (91.9) | 6726 (75.4) | 2.86 (1.68-4.86) | <.001 | |
| Use of volatile anesthetics | 129 (58.4) | 3,713 (41.6) | <.001 | 1.50 (1.12-2.03) | .006 |
| Medications | |||||
| Opioids, mean (range), IVME mg | 11.7 (10.0-16.7) | 10 (5.0-13.3) | <.001 | <.001 | |
| <5 | 0.98 (0.38-2.55) | ||||
| 5-9 | Reference | ||||
| 10-14 | 1.86 (1.24-2.80) | ||||
| ≥15 | 2.47 (1.57-3.91) | ||||
| Midazolam | 17 (7.7) | 742 (8.3) | .74 | 1.48 (0.89-2.46) | .19 |
| NDMR | 17 (7.7) | 679 (7.6) | .95 | 1.03 (0.59-1.78) | .92 |
IVME = intravenous morphine equivalents; NDMR = nondepolarizing muscle relaxant.
Values are presented as number and percentage of patients unless specified otherwise.
Morbid obesity is defined as body mass index ≥40 kg/m2.
The most frequently used opioid in this cohort was fentanyl (n=8919; 97.6%).